Novo Nordisk Sues Eli Lilly Over GLP-1 Advertising Claims

Novo Nordisk has filed a lawsuit against Eli Lilly, alleging false advertising related to their competing GLP-1 medications. The dispute centers on claims that Lilly's marketing campaigns for Zepbound and Mounjaro misrepresent clinical data by comparing lower-dose versions of Novo Nordisk’s Wegovy and Ozempic while omitting higher-approved doses.

By Fiona Craig Tue, July 21, 2026 at 4:50 PM GMT+3 3 min read · Yahoo Finance · July 21, 2026, 13:50 UTC

Tickers: $LLY $NVO

Topics: GLP-1 drugs Litigation Pharmaceuticals

Read the full article at Yahoo Finance

More Politics news

Pomerantz Law Firm Investigates HCA Healthcare Following Reduced Profit Guidance PR Newswire · November 12, 2026, 16:25 UTC
Pomerantz Law Firm Investigates Greenland Energy (GLND) Following Short Seller Report PR Newswire · November 12, 2026, 16:15 UTC
Pomerantz Law Firm Investigates Potential Securities Fraud at Foghorn Therapeutics (FHTX) PR Newswire · November 12, 2026, 16:00 UTC
Pomerantz Law Firm Investigates VinFast Auto Ltd. Following Significant Operating Losses PR Newswire · November 12, 2026, 15:55 UTC
Class Action Lawsuit Filed Against Skechers U.S.A., Inc. Regarding Take-Private Acquisition PR Newswire · November 12, 2026, 15:00 UTC
Class Action Lawsuit Filed Against Compass, Inc. Regarding Merger Disclosures PR Newswire · November 12, 2026, 15:00 UTC
Scott Colom Defeats Incumbent Cindy Hyde-Smith in Mississippi Senate Election CNBC · November 11, 2026, 23:03 UTC
Advocacy Groups Prepare to Pressure Politicians Over Data Center Restrictions Following Midterm Elections The Verge · November 11, 2026, 21:56 UTC
Alleged Security Concerns Involving Nvidia CEO Jensen Huang Prompt US-Taiwan Official Concern The Verge · November 11, 2026, 19:22 UTC
Scott Colom Maintains Narrow Lead Over Cindy Hyde-Smith in Mississippi Senate Race CNBC · November 10, 2026, 21:55 UTC